Free Trial
NASDAQ:HILS

Hillstream BioPharma (HILS) Stock Price, News & Analysis

Hillstream BioPharma logo
$1.73 +0.25 (+16.89%)
As of 04/30/2025

About Hillstream BioPharma Stock (NASDAQ:HILS)

Key Stats

Today's Range
$1.48
$1.75
50-Day Range
$1.06
$1.73
52-Week Range
$0.19
$2.65
Volume
539,054 shs
Average Volume
1.39 million shs
Market Capitalization
$30.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.

Receive HILS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hillstream BioPharma and its competitors with MarketBeat's FREE daily newsletter.

HILS Stock News Headlines

Hill & Smith PLC HILS
Kiromic BioPharma Inc Ordinary Shares KRBP
Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
See More Headlines

HILS Stock Analysis - Frequently Asked Questions

Hillstream BioPharma's stock was trading at $2.06 at the beginning of the year. Since then, HILS stock has decreased by 16.0% and is now trading at $1.73.
View the best growth stocks for 2025 here
.

Hillstream BioPharma (HILS) raised $21 million in an IPO on Wednesday, January 12th 2022. The company issued 3,750,000 shares at $5.00-$6.00 per share.

Shares of HILS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hillstream BioPharma investors own include Absci (ABSI), Luminar Technologies (LAZR), Agnico Eagle Mines (AEM), Amprius Technologies (AMPX), Atai Life Sciences (ATAI), BioTelemetry (BEAT) and BioSig Technologies (BSGM).

Company Calendar

Today
5/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:HILS
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.48 per share
Price / Book
3.60

Miscellaneous

Free Float
12,280,000
Market Cap
$30.45 million
Optionable
Not Optionable
Beta
3.08
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:HILS) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners